共 50 条
- [1] Binimetinib, encorafenib and cetuximab (BEACON Trial) combination therapy for patients with BRAF V600E-mutant metastatic colorectal cancerDRUGS OF TODAY, 2019, 55 (11) : 683 - 693Shahjehan, F.论文数: 0 引用数: 0 h-index: 0机构: Conemaugh Mem Med Ctr, Dept Internal Med, Johnstown, PA USA Conemaugh Mem Med Ctr, Dept Internal Med, Johnstown, PA USAKamatham, S.论文数: 0 引用数: 0 h-index: 0机构: Wayne State Univ, Dept Canc Biol Pathol, Detroit, MI USA Conemaugh Mem Med Ctr, Dept Internal Med, Johnstown, PA USAChandrasekharan, C.论文数: 0 引用数: 0 h-index: 0机构: Univ Iowa, Dept Hematol Oncol, Iowa City, IA 52242 USA Conemaugh Mem Med Ctr, Dept Internal Med, Johnstown, PA USAKasi, P. M.论文数: 0 引用数: 0 h-index: 0机构: Univ Iowa, Dept Hematol Oncol, Iowa City, IA 52242 USA Conemaugh Mem Med Ctr, Dept Internal Med, Johnstown, PA USA
- [2] Management of adverse events associated with encorafenib plus cetuximab in patients with BRAF V600E mutant metastatic colorectal cancer (BEACON CRC Study)ANNALS OF ONCOLOGY, 2020, 31 : S1276 - S1276Chiu, C-F.论文数: 0 引用数: 0 h-index: 0机构: China Med Univ Hosp, Med Oncol, Taichung, Taiwan China Med Univ Hosp, Med Oncol, Taichung, TaiwanYeh, Y-M.论文数: 0 引用数: 0 h-index: 0机构: NCKUH Natl Cheng Kung Univ Hosp, Med Oncol Dept, Tainan, Taiwan China Med Univ Hosp, Med Oncol, Taichung, TaiwanYeh, K-H.论文数: 0 引用数: 0 h-index: 0机构: Natl Taiwan Univ Hosp, Dept Oncol, New Taipei, Taiwan China Med Univ Hosp, Med Oncol, Taichung, TaiwanDesai, J.论文数: 0 引用数: 0 h-index: 0机构: Peter MacCallum Canc Ctr, Med Oncol, Melbourne, Vic, Australia China Med Univ Hosp, Med Oncol, Taichung, TaiwanPrice, T. J.论文数: 0 引用数: 0 h-index: 0机构: Queen Elizabeth Hosp, Emergency Dept, Med Oncol, Woodville, SA, Australia China Med Univ Hosp, Med Oncol, Taichung, TaiwanTebbutt, N.论文数: 0 引用数: 0 h-index: 0机构: Darebin St Specialist Med Ctr, Med Oncol, Heidelberg, Vic, Australia China Med Univ Hosp, Med Oncol, Taichung, TaiwanTabernero, J.论文数: 0 引用数: 0 h-index: 0机构: Vall dHebron Univ Hosp, Med Oncol Dept, Barcelona, Spain China Med Univ Hosp, Med Oncol, Taichung, TaiwanVelez, L.论文数: 0 引用数: 0 h-index: 0机构: Vall dHebron Univ Hosp, Med Oncol Dept, Barcelona, Spain China Med Univ Hosp, Med Oncol, Taichung, TaiwanTrevino, T. L.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA China Med Univ Hosp, Med Oncol, Taichung, TaiwanGrothey, A.论文数: 0 引用数: 0 h-index: 0机构: West Canc Ctr, Med Oncol Dept, Germantown, MN USA China Med Univ Hosp, Med Oncol, Taichung, TaiwanYaeger, R.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA China Med Univ Hosp, Med Oncol, Taichung, TaiwanGollerkeri, A.论文数: 0 引用数: 0 h-index: 0机构: Array BioPharma Inc, Clin Operat, Cambridge, MA USA China Med Univ Hosp, Med Oncol, Taichung, TaiwanMaharry, K.论文数: 0 引用数: 0 h-index: 0机构: Array BioPharma Inc, Clin Sci, Cambridge, MA USA China Med Univ Hosp, Med Oncol, Taichung, TaiwanKopetz, S.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, GI Med Oncol Dept, Houston, TX 77030 USA China Med Univ Hosp, Med Oncol, Taichung, Taiwan
- [3] Management of adverse events associated with encorafenib plus cetuximab in patients with BRAF V600E-mutant metastatic colorectal cancer (The BEACON CRC Study)ANNALS OF ONCOLOGY, 2020, 31 : S224 - S225Velez, L.论文数: 0 引用数: 0 h-index: 0机构: Vall dHebron Univ Hosp, Barcelona, Spain Vall dHebron Inst Oncol, Barcelona, Spain Vall dHebron Univ Hosp, Barcelona, SpainTrevino, T.论文数: 0 引用数: 0 h-index: 0机构: Univ Tennessee, West Canc Ctr, Germantown, TN USA Vall dHebron Univ Hosp, Barcelona, SpainKopetz, S.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA Vall dHebron Univ Hosp, Barcelona, Spain论文数: 引用数: h-index:机构:Yaeger, R.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA Vall dHebron Univ Hosp, Barcelona, SpainGollerkeri, A.论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, New York, NY USA Vall dHebron Univ Hosp, Barcelona, SpainMaharry, K.论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, New York, NY USA Vall dHebron Univ Hosp, Barcelona, SpainTabernero, J.论文数: 0 引用数: 0 h-index: 0机构: Vall dHebron Univ Hosp, Barcelona, Spain Vall dHebron Inst Oncol, Barcelona, Spain Vall dHebron Univ Hosp, Barcelona, Spain
- [4] Molecular mechanisms underlying the resistance of BRAF V600E-mutant metastatic colorectal cancer to EGFR/BRAF inhibitorsTHERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2022, 14Xu, Ting论文数: 0 引用数: 0 h-index: 0机构: Peking Univ, Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Dept Gastrointestinal Oncol,Minist Educ, 52 Fucheng Rd, Beijing 100142, Peoples R China Peking Univ, Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Dept Gastrointestinal Oncol,Minist Educ, 52 Fucheng Rd, Beijing 100142, Peoples R ChinaWang, Xicheng论文数: 0 引用数: 0 h-index: 0机构: Peking Univ, Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Dept Gastrointestinal Oncol,Minist Educ, 52 Fucheng Rd, Beijing 100142, Peoples R China Peking Univ, Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Dept Gastrointestinal Oncol,Minist Educ, 52 Fucheng Rd, Beijing 100142, Peoples R ChinaWang, Zhenghang论文数: 0 引用数: 0 h-index: 0机构: Peking Univ, Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Dept Gastrointestinal Oncol,Minist Educ, 52 Fucheng Rd, Beijing 100142, Peoples R China Peking Univ, Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Dept Gastrointestinal Oncol,Minist Educ, 52 Fucheng Rd, Beijing 100142, Peoples R ChinaDeng, Ting论文数: 0 引用数: 0 h-index: 0机构: Tianjin Med Univ Canc Inst & Hosp, Key Lab Canc Prevent & Therapy, Tianjins Clin Res Ctr Canc, Natl Clin Res Ctr Canc, Tianjin, Peoples R China Peking Univ, Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Dept Gastrointestinal Oncol,Minist Educ, 52 Fucheng Rd, Beijing 100142, Peoples R ChinaQi, Changsong论文数: 0 引用数: 0 h-index: 0机构: Peking Univ, Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Dept Gastrointestinal Oncol,Minist Educ, 52 Fucheng Rd, Beijing 100142, Peoples R China Peking Univ, Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Dept Gastrointestinal Oncol,Minist Educ, 52 Fucheng Rd, Beijing 100142, Peoples R ChinaLiu, Dan论文数: 0 引用数: 0 h-index: 0机构: Peking Univ, Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Dept Gastrointestinal Oncol,Minist Educ, 52 Fucheng Rd, Beijing 100142, Peoples R China Peking Univ, Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Dept Gastrointestinal Oncol,Minist Educ, 52 Fucheng Rd, Beijing 100142, Peoples R ChinaLi, Yanyan论文数: 0 引用数: 0 h-index: 0机构: Peking Univ, Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Dept Gastrointestinal Oncol,Minist Educ, 52 Fucheng Rd, Beijing 100142, Peoples R China Peking Univ, Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Dept Gastrointestinal Oncol,Minist Educ, 52 Fucheng Rd, Beijing 100142, Peoples R ChinaJi, Congcong论文数: 0 引用数: 0 h-index: 0机构: Peking Univ, Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Dept Gastrointestinal Oncol,Minist Educ, 52 Fucheng Rd, Beijing 100142, Peoples R China Peking Univ, Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Dept Gastrointestinal Oncol,Minist Educ, 52 Fucheng Rd, Beijing 100142, Peoples R ChinaLi, Jian论文数: 0 引用数: 0 h-index: 0机构: Peking Univ, Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Dept Gastrointestinal Oncol,Minist Educ, 52 Fucheng Rd, Beijing 100142, Peoples R China Peking Univ, Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Dept Gastrointestinal Oncol,Minist Educ, 52 Fucheng Rd, Beijing 100142, Peoples R ChinaShen, Lin论文数: 0 引用数: 0 h-index: 0机构: Peking Univ, Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Dept Gastrointestinal Oncol,Minist Educ, 52 Fucheng Rd, Beijing 100142, Peoples R China Peking Univ, Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Dept Gastrointestinal Oncol,Minist Educ, 52 Fucheng Rd, Beijing 100142, Peoples R China
- [5] Effect of prior bevacizumab treatment in BRAF V600E-mutant metastatic colorectal cancer: Overall survival with encorafenib plus cetuximab plus /- binimetinib in BEACON CRCANNALS OF ONCOLOGY, 2021, 32 : S214 - S214Aderka, D.论文数: 0 引用数: 0 h-index: 0机构: Sheba Med Ctr, Tel Hashomer, Israel Sheba Med Ctr, Tel Hashomer, IsraelKopetz, S.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA Sheba Med Ctr, Tel Hashomer, IsraelGrothey, A.论文数: 0 引用数: 0 h-index: 0机构: OneOncology, West Canc Ctr, Germantown, TN USA Sheba Med Ctr, Tel Hashomer, IsraelVan Cutsem, E.论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Leuven, Dept Digest Oncol, Leuven, Belgium Katholieke Univ Leuven, Leuven, Belgium Sheba Med Ctr, Tel Hashomer, IsraelYaeger, R.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA Sheba Med Ctr, Tel Hashomer, IsraelWasan, H.论文数: 0 引用数: 0 h-index: 0机构: Imperial Coll London, Hammersmith Hosp, Div Canc, London, England Sheba Med Ctr, Tel Hashomer, IsraelYoshino, T.论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan Sheba Med Ctr, Tel Hashomer, IsraelDesai, J.论文数: 0 引用数: 0 h-index: 0机构: Peter MacCallum Canc Ctr, Melbourne, Vic, Australia Sheba Med Ctr, Tel Hashomer, IsraelCiardiello, F.论文数: 0 引用数: 0 h-index: 0机构: Univ Campania Luigi Vanvitelli, Naples, Italy Sheba Med Ctr, Tel Hashomer, IsraelGolden, A.论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, New York, NY USA Sheba Med Ctr, Tel Hashomer, IsraelEdwards, M.论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, New York, NY USA Sheba Med Ctr, Tel Hashomer, IsraelTabernero, J.论文数: 0 引用数: 0 h-index: 0机构: Vall dHebron Univ Hosp, Barcelona, Spain Vall dHebron Inst Oncol, Barcelona, Spain Sheba Med Ctr, Tel Hashomer, Israel
- [6] Overall survival (OS) with encorafenib (enco) plus cetuximab (cetux) in BEACON CRC: Effect of prior therapy for BRAF V600E-mutant metastatic colorectal cancer (mCRC).JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)Kopetz, Scott论文数: 0 引用数: 0 h-index: 0机构: MD Anderson Canc Ctr, Houston, TX USAAderka, Dan论文数: 0 引用数: 0 h-index: 0机构: MD Anderson Canc Ctr, Houston, TX USAGrothey, Axel论文数: 0 引用数: 0 h-index: 0机构: MD Anderson Canc Ctr, Houston, TX USAVan Cutsem, Eric论文数: 0 引用数: 0 h-index: 0机构: MD Anderson Canc Ctr, Houston, TX USAYaeger, Rona论文数: 0 引用数: 0 h-index: 0机构: MD Anderson Canc Ctr, Houston, TX USAWasan, Harpreet Singh论文数: 0 引用数: 0 h-index: 0机构: MD Anderson Canc Ctr, Houston, TX USAYoshino, Takayuki论文数: 0 引用数: 0 h-index: 0机构: MD Anderson Canc Ctr, Houston, TX USADesai, Jayesh论文数: 0 引用数: 0 h-index: 0机构: MD Anderson Canc Ctr, Houston, TX USACiardiello, Fortunato论文数: 0 引用数: 0 h-index: 0机构: MD Anderson Canc Ctr, Houston, TX USAGollerkeri, Ashwin论文数: 0 引用数: 0 h-index: 0机构: MD Anderson Canc Ctr, Houston, TX USAGolden, Adele论文数: 0 引用数: 0 h-index: 0机构: MD Anderson Canc Ctr, Houston, TX USAEdwards, Michelle L.论文数: 0 引用数: 0 h-index: 0机构: MD Anderson Canc Ctr, Houston, TX USATabernero, Josep论文数: 0 引用数: 0 h-index: 0机构: MD Anderson Canc Ctr, Houston, TX USA
- [7] Overall survival (OS) with encorafenib (enco) plus cetuximab (cetux) in BEACON CRC: Effect of prior therapy for BRAF V600E-mutant metastatic colorectal cancer (mCRC)ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 : 119 - 120Desai, Jayesh论文数: 0 引用数: 0 h-index: 0机构: PeterMacCallum Canc Ctr, Melbourne, Vic, Australia PeterMacCallum Canc Ctr, Melbourne, Vic, AustraliaKopetz, Scott论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA PeterMacCallum Canc Ctr, Melbourne, Vic, AustraliaAderka, Dan论文数: 0 引用数: 0 h-index: 0机构: Sheba Med Ctr, Tel Hashomer, Israel PeterMacCallum Canc Ctr, Melbourne, Vic, AustraliaGrothey, Axel论文数: 0 引用数: 0 h-index: 0机构: West Canc Ctr, OneOncol, Germantown, TN USA PeterMacCallum Canc Ctr, Melbourne, Vic, AustraliaVan Cutsem, Eric论文数: 0 引用数: 0 h-index: 0机构: Univ Leuven, Univ Hosp Gasthuisberg, Leuven, Belgium PeterMacCallum Canc Ctr, Melbourne, Vic, AustraliaYaeger, Rona论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA PeterMacCallum Canc Ctr, Melbourne, Vic, AustraliaWasan, Harpreet Singh论文数: 0 引用数: 0 h-index: 0机构: Hammersmith Hosp, Div Canc, Imperial Coll London, London, England PeterMacCallum Canc Ctr, Melbourne, Vic, AustraliaYoshino, Takayuki论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan PeterMacCallum Canc Ctr, Melbourne, Vic, AustraliaCiardiello, Fortunato论文数: 0 引用数: 0 h-index: 0机构: Univ Campania Luigi Vanvitelli, Naples, Italy PeterMacCallum Canc Ctr, Melbourne, Vic, AustraliaChantrill, Lorraine论文数: 0 引用数: 0 h-index: 0机构: St Vincents Hosp, Sydney, NSW, Australia PeterMacCallum Canc Ctr, Melbourne, Vic, AustraliaTebbutt, Niall论文数: 0 引用数: 0 h-index: 0机构: Austin Hlth, Med Oncol, Melbourne, Vic, Australia PeterMacCallum Canc Ctr, Melbourne, Vic, AustraliaStrickland, Andrew论文数: 0 引用数: 0 h-index: 0机构: Monash Hlth & Monash Univ, Melbourne, Vic, Australia PeterMacCallum Canc Ctr, Melbourne, Vic, AustraliaPrice, Timothy论文数: 0 引用数: 0 h-index: 0机构: Univ Adelaide, Med Oncol Unit, South Australia, Australia Queen Elizabeth Hosp, Adelaide, SA, Australia PeterMacCallum Canc Ctr, Melbourne, Vic, AustraliaKarapetis, Chris论文数: 0 引用数: 0 h-index: 0机构: Flinders Med Ctr & Flinders Univ, Adelaide, SA, Australia PeterMacCallum Canc Ctr, Melbourne, Vic, AustraliaMurphy, Felicity论文数: 0 引用数: 0 h-index: 0机构: Mater Hosp, Brisbane, Qld, Australia PeterMacCallum Canc Ctr, Melbourne, Vic, AustraliaGollerkeri, Ashwin论文数: 0 引用数: 0 h-index: 0机构: Pfizer, New York, NY USA PeterMacCallum Canc Ctr, Melbourne, Vic, AustraliaGolden, Adele论文数: 0 引用数: 0 h-index: 0机构: Pfizer, New York, NY USA PeterMacCallum Canc Ctr, Melbourne, Vic, AustraliaEdwards, Michelle L.论文数: 0 引用数: 0 h-index: 0机构: Pfizer, New York, NY USA PeterMacCallum Canc Ctr, Melbourne, Vic, AustraliaTabernero, Josep论文数: 0 引用数: 0 h-index: 0机构: Vall dHebron Univ Hosp, UVic UCC, Barcelona, Spain Vall dHebron Inst Oncol, Barcelona, Spain PeterMacCallum Canc Ctr, Melbourne, Vic, Australia
- [8] Management of adverse events from the treatment of encorafenib plus cetuximab for patients with BRAF V600E-mutant metastatic colorectal cancer: insights from the BEACON CRC studyESMO OPEN, 2021, 6 (06)Tabernero, J.论文数: 0 引用数: 0 h-index: 0机构: Med Oncol Dept, Vall dHebron Hosp Campus, Barcelona, Spain Vall dHebron Inst Oncol VHIO, UVIC UCC, IOB Quiron, Barcelona, Spain Med Oncol Dept, Vall dHebron Hosp Campus, Barcelona, SpainVelez, L.论文数: 0 引用数: 0 h-index: 0机构: Med Oncol Dept, Vall dHebron Hosp Campus, Barcelona, Spain Vall dHebron Inst Oncol VHIO, UVIC UCC, IOB Quiron, Barcelona, Spain Med Oncol Dept, Vall dHebron Hosp Campus, Barcelona, SpainTrevino, T. L.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA Med Oncol Dept, Vall dHebron Hosp Campus, Barcelona, SpainGrothey, A.论文数: 0 引用数: 0 h-index: 0机构: OneOncology, West Canc Ctr & Res Inst, Germantown, TN USA Med Oncol Dept, Vall dHebron Hosp Campus, Barcelona, SpainYaeger, R.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA Med Oncol Dept, Vall dHebron Hosp Campus, Barcelona, SpainVan Cutsem, E.论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Gasthuisberg Leuven, Digest Oncol Dept, Leuven, Belgium Katholieke Univ Leuven, Leuven, Belgium Med Oncol Dept, Vall dHebron Hosp Campus, Barcelona, SpainWasan, H.论文数: 0 引用数: 0 h-index: 0机构: Hammersmith Hosp, Dept Canc Med, London, England Med Oncol Dept, Vall dHebron Hosp Campus, Barcelona, SpainDesai, J.论文数: 0 引用数: 0 h-index: 0机构: Royal Melbourne Hosp, Dept Med Oncol, Parkville, Vic, Australia Peter MacCallum Canc Ctr, Walter & Aliza Hall Inst, Parkville, Vic, Australia Med Oncol Dept, Vall dHebron Hosp Campus, Barcelona, SpainCiardiello, F.论文数: 0 引用数: 0 h-index: 0机构: Univ Campania, Dept Precis Med, Naples, Italy Med Oncol Dept, Vall dHebron Hosp Campus, Barcelona, SpainYoshino, T.论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr Hosp East, Dept Gastroenterol & Gastrointestinal Oncol, Kashiwa, Chiba, Japan Med Oncol Dept, Vall dHebron Hosp Campus, Barcelona, SpainGollerkeri, A.论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, New York, NY USA Med Oncol Dept, Vall dHebron Hosp Campus, Barcelona, SpainMaharry, K.论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, New York, NY USA Med Oncol Dept, Vall dHebron Hosp Campus, Barcelona, SpainChristy-Bittel, J.论文数: 0 引用数: 0 h-index: 0机构: Pfizer Inc, New York, NY USA Med Oncol Dept, Vall dHebron Hosp Campus, Barcelona, SpainKopetz, S.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA Med Oncol Dept, Vall dHebron Hosp Campus, Barcelona, Spain
- [9] BEACON CRC: a randomized, 3-Arm, phase 3 study of encorafenib and cetuximab with or without binimetinib vs, choice of either irinotecan or FOLFIRI plus cetuximab in BRAF V600E-mutant metastatic colorectal cancerANNALS OF ONCOLOGY, 2019, 30Kopetz, S.论文数: 0 引用数: 0 h-index: 0机构: UT MD Anderson Canc Ctr, Houston, TX USA UT MD Anderson Canc Ctr, Houston, TX USACrothey, A.论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Rochester, MN USA UT MD Anderson Canc Ctr, Houston, TX USAVan Cutsem, E.论文数: 0 引用数: 0 h-index: 0机构: UZ Leuven Campus Gasthuisberg, Leuven, Belgium UT MD Anderson Canc Ctr, Houston, TX USAYaeger, R.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA UT MD Anderson Canc Ctr, Houston, TX USAWasan, H.论文数: 0 引用数: 0 h-index: 0机构: Hammersmith Hosp, Dept Canc Med, London, England UT MD Anderson Canc Ctr, Houston, TX USAYoshino, T.论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Hosp East, Dept Gastroenterol & Gastrointestinal Oncol, Kashiwa, Chiba, Japan UT MD Anderson Canc Ctr, Houston, TX USADesai, J.论文数: 0 引用数: 0 h-index: 0机构: Royal Melbourne Hosp, Parkville, Vic, Australia Walter & Eliza Hall Inst Med Res, Peter MacCallum Canc Ctr, Parkville, Vic, Australia UT MD Anderson Canc Ctr, Houston, TX USACiardiello, F.论文数: 0 引用数: 0 h-index: 0机构: Univ Campania L, Dipartimento Med Precis, Naples, Italy UT MD Anderson Canc Ctr, Houston, TX USAGollerkeri, F.论文数: 0 引用数: 0 h-index: 0机构: Array BioPharma Inc, Boulder, CO USA UT MD Anderson Canc Ctr, Houston, TX USAMaharry, K.论文数: 0 引用数: 0 h-index: 0机构: Array BioPharma Inc, Boulder, CO USA UT MD Anderson Canc Ctr, Houston, TX USALoupakis, F.论文数: 0 引用数: 0 h-index: 0机构: Veneto Inst Oncol IOV IRCCS, Med Oncol Unit 1, Clin & Expt Oncol Dept, Padua, Italy UT MD Anderson Canc Ctr, Houston, TX USAHong, Y.论文数: 0 引用数: 0 h-index: 0机构: Asan Med Ctr, Seoul, South Korea UT MD Anderson Canc Ctr, Houston, TX USASteeghs, F.论文数: 0 引用数: 0 h-index: 0机构: Netherlands Canc Inst, Amsterdam, Netherlands UT MD Anderson Canc Ctr, Houston, TX USAGuren, T.论文数: 0 引用数: 0 h-index: 0机构: Oslo Univ Hosp, Oslo, Norway UT MD Anderson Canc Ctr, Houston, TX USAArkenau, H.论文数: 0 引用数: 0 h-index: 0机构: HCA Healthcare, Sarah Cannon Res Inst, London, England UT MD Anderson Canc Ctr, Houston, TX USAGarcia Alfonso, P.论文数: 0 引用数: 0 h-index: 0机构: Hosp Gen Univ Gregorio Maranon, Med Oncol Dept, Madrid, Spain UT MD Anderson Canc Ctr, Houston, TX USASandor, V.论文数: 0 引用数: 0 h-index: 0机构: Array BioPharma Inc, Cambridge, MA USA UT MD Anderson Canc Ctr, Houston, TX USAChristy-Bittel, J.论文数: 0 引用数: 0 h-index: 0机构: Array BioPharma Inc, Boulder, CO USA UT MD Anderson Canc Ctr, Houston, TX USAAnderson, L.论文数: 0 引用数: 0 h-index: 0机构: Array BioPharma, Boulder, CO USA UT MD Anderson Canc Ctr, Houston, TX USATabernero, J.论文数: 0 引用数: 0 h-index: 0机构: VAll dHebron Univ Hosp, Barcelona, Spain UT MD Anderson Canc Ctr, Houston, TX USA
- [10] Molecular correlates of clinical benefit in previously treated patients (pts) with BRAF V600E-mutant metastatic colorectal cancer (mCRC) from the BEACON studyASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 : 89 - 89Desai, Jayesh论文数: 0 引用数: 0 h-index: 0机构: Peter MacCallum Canc Ctr, Melbourne, Vic, Australia Peter MacCallum Canc Ctr, Melbourne, Vic, AustraliaKopetz, Scott论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA Peter MacCallum Canc Ctr, Melbourne, Vic, AustraliaMurphy, Danielle A.论文数: 0 引用数: 0 h-index: 0机构: Pfizer, La Jolla, CA USA Peter MacCallum Canc Ctr, Melbourne, Vic, AustraliaPu, Jie论文数: 0 引用数: 0 h-index: 0机构: Pfizer, La Jolla, CA USA Peter MacCallum Canc Ctr, Melbourne, Vic, AustraliaCiardiello, Fortunato论文数: 0 引用数: 0 h-index: 0机构: Univ Campania Luigi Vanvitelli, Naples, Italy Peter MacCallum Canc Ctr, Melbourne, Vic, AustraliaGrothey, Axel论文数: 0 引用数: 0 h-index: 0机构: OneOncology, West Canc Ctr, Germantown, TN USA Peter MacCallum Canc Ctr, Melbourne, Vic, AustraliaVan Cutsem, Eric论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Gasthuisberg, Leuven, Belgium Univ Leuven, Leuven, Belgium Peter MacCallum Canc Ctr, Melbourne, Vic, AustraliaWasan, Harpreet Singh论文数: 0 引用数: 0 h-index: 0机构: Imperial Coll London, Hammersmith Hosp, Div Canc, London, England Peter MacCallum Canc Ctr, Melbourne, Vic, AustraliaYaeger, Rona论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA Peter MacCallum Canc Ctr, Melbourne, Vic, AustraliaYoshino, Takayuki论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan Peter MacCallum Canc Ctr, Melbourne, Vic, AustraliaChantrill, Lorraine论文数: 0 引用数: 0 h-index: 0机构: St Vincents Hosp, Sydney, NSW, Australia Peter MacCallum Canc Ctr, Melbourne, Vic, AustraliaTebbutt, Niall论文数: 0 引用数: 0 h-index: 0机构: Austin Hlth, Med Oncol, Melbourne, Vic, Australia Peter MacCallum Canc Ctr, Melbourne, Vic, AustraliaStrickland, Andrew论文数: 0 引用数: 0 h-index: 0机构: Monash Hlth, Melbourne, Vic, Australia Monash Univ, Melbourne, Vic, Australia Peter MacCallum Canc Ctr, Melbourne, Vic, AustraliaPrice, Timothy论文数: 0 引用数: 0 h-index: 0机构: Queen Elizabeth Hosp, Med Oncol Unit, Adelaide, SA, Australia Univ Adelaide, Adelaide, SA, Australia Peter MacCallum Canc Ctr, Melbourne, Vic, AustraliaKarapetis, Chris论文数: 0 引用数: 0 h-index: 0机构: Flinders Med Ctr, Adelaide, SA, Australia Flinders Univ S Australia, Adelaide, SA, Australia Peter MacCallum Canc Ctr, Melbourne, Vic, AustraliaMurphy, Felicity论文数: 0 引用数: 0 h-index: 0机构: Mater Hosp, Brisbane, Qld, Australia Peter MacCallum Canc Ctr, Melbourne, Vic, AustraliaDonahue, Amber C.论文数: 0 引用数: 0 h-index: 0机构: Pfizer, La Jolla, CA USA Peter MacCallum Canc Ctr, Melbourne, Vic, AustraliaGolden, Adele论文数: 0 引用数: 0 h-index: 0机构: Pfizer, Cambridge, MA USA Peter MacCallum Canc Ctr, Melbourne, Vic, AustraliaGollerkeri, Ashwin论文数: 0 引用数: 0 h-index: 0机构: Pfizer, New York, NY USA Peter MacCallum Canc Ctr, Melbourne, Vic, AustraliaZhu, Zhou论文数: 0 引用数: 0 h-index: 0机构: Pfizer, La Jolla, CA USA Peter MacCallum Canc Ctr, Melbourne, Vic, AustraliaTabernero, Josep论文数: 0 引用数: 0 h-index: 0机构: UCC, UVic, Vall dHebron Univ Hosp, Barcelona, Spain UCC, UVic, Vall dHebron Inst Oncol VHIO, Barcelona, Spain Peter MacCallum Canc Ctr, Melbourne, Vic, Australia